DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Symadine is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in SYMADINE is amantadine hydrochloride. There are seven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the amantadine hydrochloride profile page.
A generic version of SYMADINE was approved as amantadine hydrochloride by UPSHER SMITH LABS on August 5th, 1986.
Recent Clinical Trials for SYMADINE
Identify potential brand extensions & 505(b)(2) entrants
|Columbia University||Phase 4|
|Edward Hines Jr. VA Hospital||N/A|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Solvay||SYMADINE||amantadine hydrochloride||CAPSULE;ORAL||071000-001||Sep 4, 1986||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|